Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

BACKGROUND: New immuno-oncology (I-O) therapies that harness the immune system to fight cancer call for a re-examination of the traditional parametric techniques used to model survival from clinical trial data. More flexible approaches are needed to capture the characteristic I-O pattern of delayed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacoeconomics
Main Authors: Gibson, Eddie, Koblbauer, Ian, Begum, Najida, Dranitsaris, George, Liew, Danny, McEwan, Phil, Tahami Monfared, Amir Abbas, Yuan, Yong, Juarez-Garcia, Ariadna, Tyas, David, Lees, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5684270/
https://ncbi.nlm.nih.gov/pubmed/28866758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-017-0558-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados